Liquidia (LQDA) Retained Earnings (2019 - 2026)
Liquidia's (LQDA) quarterly Retained Earnings came in at -$573.5 million in Q1 2026, up 3.75% year-on-year from -$552.7 million in Q1 2025, and down 185.47% quarter-over-quarter from $671.0 million in Q4 2025.
Liquidia (LQDA) Retained Earnings (2019 - 2026) Analysis & Trends
Liquidia's Retained Earnings history runs 8 years deep, the most recent figure standing at -$573.5 million for Q1 2026.
- On a quarterly basis, Retained Earnings rose 3.75% year-over-year to -$573.5 million in Q1 2026; TTM through Mar 2026 was -$573.5 million, a 3.75% increase from a year earlier, with the FY2025 full-year figure at $671.0 million, up 5.39% from the prior year.
- Retained Earnings slipped to -$573.5 million in Q1 2026 per LQDA's latest filing, from $671.0 million in the prior quarter.
- Across five years, Retained Earnings topped out at $671.0 million in Q4 2025 and bottomed at -$637.3 million in Q2 2025.
- The 5-year median for Retained Earnings is $380.9 million (2022), against an average of $67.8 million.
- Across the five-year window, Retained Earnings jumped 257.26% in 2024 and sank 213.69% in 2025, its largest moves.
- Year by year, Retained Earnings stood at -$350.6 million in 2022, then soared by 235.86% to $476.3 million in 2023, then soared by 33.67% to $636.7 million in 2024, then rose by 5.39% to $671.0 million in 2025, then sank by 185.47% to -$573.5 million in 2026.
- Per Business Quant, the three latest LQDA Retained Earnings figures stand at -$573.5 million (Q1 2026), $671.0 million (Q4 2025), and $662.8 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Liquidia | 7.84 Bn | 7.61 Bn | 121.79 Mn | -573.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -573.45 Mn |
| Dec 31, 2025 | 670.97 Mn |
| Sep 30, 2025 | 662.83 Mn |
| Jun 30, 2025 | -637.34 Mn |
| Mar 31, 2025 | -595.80 Mn |
| Dec 31, 2024 | 636.68 Mn |
| Sep 30, 2024 | 631.56 Mn |
| Jun 30, 2024 | 560.61 Mn |
| Mar 31, 2024 | -459.18 Mn |
| Dec 31, 2023 | 476.32 Mn |
| Sep 30, 2023 | -401.60 Mn |
| Jun 30, 2023 | -385.86 Mn |
| Mar 31, 2023 | 443.92 Mn |
| Dec 31, 2022 | -350.60 Mn |
| Sep 30, 2022 | -344.10 Mn |
| Jun 30, 2022 | 437.01 Mn |
| Mar 31, 2022 | 380.86 Mn |
| Dec 31, 2021 | -309.58 Mn |
| Sep 30, 2021 | 370.93 Mn |
| Jun 30, 2021 | -290.70 Mn |